CytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual Audit
Provided By PR Newswire
Last update: Mar 21, 2025
The Company reaffirms previously provided preliminary financial results for the quarter and full year ended December 31, 2024, and continues to expect regulatory decisions on DrugSorb™-ATR marketing applications in 2025
Read more at prnewswire.com0.9131
+0.07 (+8.19%)
Find more stocks in the Stock Screener
CTSO Latest News and Analysis
18 days ago - By: Chartmill
